Company Hangzhou Biotest Biotech Co.,Ltd.

Equities

688767

CNE1000050H0

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
29.31 ^CNY	0.00%		+1.52%	-3.17%

04-26	Hangzhou Biotest Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-23	Hangzhou Biotest Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hangzhou Biotest Biotech Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of point-of-care testing (POCT) diagnostic reagents. The Company's products include reproductive health testing series, such as human chorionic gonadotropin testing reagent and luteinizing hormone testing reagent, and drug abuse testing series, such as morphine testing reagent and cocaine testing reagent, and infectious disease testing series, such as adenovirus testing reagent and typhoid antibody testing reagent, and tumor marker testing series, such as alpha fetoprotein detection reagent, and myocardial marker detection series, such as dimer detection reagent and myocardial series detection reagent.

Number of employees: 730

CNY in Million	2022	Weight	2023	Weight	Delta
Point-of-care Testing Diagnostic Reagents 100.0 %	1,894	100.0 %	436	100.0 %	-76.98%

CNY in Million	2022	Weight	2023	Weight	Delta
Overseas 70.7 %	0	0.0 %	308	70.7 %	-
China 29.3 %	357	18.8 %	128	29.3 %	-64.20%

Managers	Title	Age	Since
Shu Jiang Wu CEO	Chief Executive Officer	47	31/01/10
Miao Miao Yu DFI	Director of Finance/CFO	43	31/12/15
Dong Chen CTO	Chief Tech/Sci/R&D Officer	28	31/12/16
Hong Mei Gao BRD	Director/Board Member	48	31/10/13
Yu Feng Huang IRC	Investor Relations Contact	-	-
Chun Sheng Ye PRN	Corporate Officer/Principal	48	28/02/11

Members of the board	Title	Age	Since
Yin Long Chen CHM	Chairman	62	27/09/15
Shu Jiang Wu CEO	Chief Executive Officer	47	31/01/10
Yu Jie Chen BRD	Director/Board Member	34	31/08/15
Hong Mei Gao BRD	Director/Board Member	48	31/10/13
Wen Ming Wang BRD	Director/Board Member	43	31/07/20
Zuo Hong Wang CHM	Chairman	54	31/01/11
Chun Sheng Ye PRN	Corporate Officer/Principal	48	28/02/11
Guo Qing Ying BRD	Director/Board Member	59	14/06/22
Dan Yun Zhao BRD	Director/Board Member	31	06/03/22
Dong Chen CTO	Chief Tech/Sci/R&D Officer	28	31/12/16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	106,666,667	35,331,351 ( 33.12 %)	0	33.12 %

Name	Equities	%	Valuation
Qi Fu Li 8.403 %	3,333,300	8.403 %	13 M ¥
GF Fund Management Co., Ltd. 6.902 %	2,737,952	6.902 %	11 M ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd. 5.808 %	2,303,964	5.808 %	9 M ¥
Ai Ju Zhu 4.033 %	1,600,000	4.033 %	6 M ¥
Hai Jiang Wu 2.017 %	800,000	2.017 %	3 M ¥
Gang Wu Zheng 1.210 %	480,000	1.210 %	2 M ¥
Xu Jun Li 0.9075 %	360,000	0.9075 %	1 M ¥
Hong He Li 0.9075 %	360,000	0.9075 %	1 M ¥
Maxwealth Fund Management Co., Ltd. 0.3590 %	142,429	0.3590 %	563 304 ¥
Tian Hong Asset Management Co., Ltd. 0.2910 %	115,440	0.2910 %	456 563 ¥

Hangzhou Biotest Biotech Co., Ltd.

27 Tuyi Road Cangqian Street

311100, Hangzhou

http://www.biotests.com.cn

address Hangzhou Biotest Biotech Co.,Ltd.(688767)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
HANGZHOU BIOTEST BIOTECH CO.,LTD.	-3.17%	424M
BIOMÉRIEUX	-6.16%	12.1B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.26%	8.16B
DIASORIN S.P.A.	+6.61%	5.78B
LANTHEUS HOLDINGS, INC.	+31.20%	5.59B
AUTOBIO DIAGNOSTICS CO., LTD.	-9.05%	4.23B
10X GENOMICS, INC.	-56.99%	2.87B
ANDON HEALTH CO., LTD.	+11.87%	2.71B
VITROLIFE AB	-5.34%	2.35B
MYRIAD GENETICS, INC.	+25.34%	2.21B

Diagnostic & Testing Substances